Lina is a senior obstetrician and associate professor at University of Gothenburg in Sweden and Stellenbosch University in South Africa. She completed her specialist training from 2011 to 2017 and earned her PhD in 2017 at Uppsala University, focusing on preeclampsia and cerebral biomarkers. During her PhD, she spent a year in Cape Town where she initiated a biobank and database for preeclampsia together with Professor Catherine Cluver. Lina divides her time between her two research sites at Stellenbosch University in South Africa and University of Gothenburg in Sweden. She focuses on a translational approach to understand underlying causes to complications in preeclampsia. Her research also focuses on prediction of preeclampsia and its complications and discovery of novel treatment to prevent and/or treat preeclampsia.

Lina is the principal investigator for the Nordic multicenter clinical trial PI 4 (using metformin to slower disease progression in preterm preeclampsia). She is also an investigator for the biobanks PROVE (South Africa) and GO PROVE (Sweden), and the clinical cohort for first trimester prediction of pregnancy complications, the IMPACT study. She also collaborates on register-based research in the Swedish Pregnancy Register. In addition, she runs a pre-clinical preeclampsia research group in Sweden, establishing animal models for preeclampsia and eclampsia to evaluate new disease-modifying drugs. Her research is funded largely by the Wallenberg Foundation, the European Research Council and the Swedish Research council.

She supervises seven PhD students and co-supervises five others. Active in the national Swedish Preeclampsia working group, she has served on several scientific committees and is an active member of CoLab for international collaboration in preeclampsia research. Lina also reviews for several journals and is a frequent speaker at national and international conferences.